pre-IPO PHARMA

COMPANY OVERVIEW

HemoShear Therapeutics is a biotechnology company focused on discovering novel biological targets and developing drugs to treat children’s rare metabolic disorders.


LOCATION

  • Charlottesville, VA, USA

  • THERAPEUTIC AREAS

  • Metabolic Disorders
  • Rare Diseases

  • WEBSITE

    https://www.hemoshear.com/


    CAREER WEBSITE

    https://www.hemoshear.com/join-us


    SOCIAL MEDIA


    INVESTORS



    PRESS RELEASES


    Nov 17, 2022

    HemoShear Therapeutics to Participate in Piper Sandler Healthcare Conference


    Oct 18, 2022

    HemoShear Therapeutics to Participate in SVB Leerink Securities Biopharma Private Company Connect


    Sep 21, 2022

    HemoShear Therapeutics Advancing Novel Modulators Against Second Target for Horizon Therapeutics' Gout Discovery Pipeline


    Aug 25, 2022

    HemoShear Therapeutics Appoints Brian Wamhoff, PhD, Interim Chief Executive Officer


    Jun 7, 2022

    OpenBench Assigns Two AI-Discovered Series to HemoShear Therapeutics


    For More Press Releases


    Google Analytics Alternative